Skip to content

MiMedx Group, Inc.: 10-K filed 2014-03-04

What MiMedx Group, Inc. reported in its annual report filed 2014-03-04 (fiscal FY 2013): 40 published measures, 125 facts as tagged in accession 0001376339-14-000005.

This filing

Form
10-K (annual report)
Filed
2014-03-04
Fiscal period
fiscal FY 2013
Accession
0001376339-14-000005 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MiMedx Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3184,693,893USD
At 2012-12-3135,182,608USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3111,125,823USD
At 2012-12-3115,175,306USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3173,568,070USD
At 2012-12-3120,007,302USD
At 2011-12-3111,896,565USD
At 2010-12-316,100,528USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3144,077,751USD
At 2012-12-316,754,485USD
At 2011-12-314,112,326USD
At 2010-12-311,340,922USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-1,426,938USD92
2013-01-01 to 2013-12-31-4,111,853USD365
2013-07-01 to 2013-09-30-307,118USD92
2013-04-01 to 2013-06-30-757,389USD91
2013-01-01 to 2013-03-31-1,620,408USD90
2012-10-01 to 2012-12-31-1,605,283USD92
2012-01-01 to 2012-12-31-7,662,376USD366
2012-07-01 to 2012-09-30-4,219,372USD92
2012-04-01 to 2012-06-30-744,069USD91
2012-01-01 to 2012-03-31-1,093,652USD91
2011-10-01 to 2011-12-31-2,577,196USD92
2011-01-01 to 2011-12-31-10,193,986USD365
2011-07-01 to 2011-09-30-1,765,723USD92
2011-04-01 to 2011-06-30-2,503,505USD91
2011-01-01 to 2011-03-31-3,347,562USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-285,477USD365
2012-01-01 to 2012-12-31-3,331,260USD366
2011-01-01 to 2011-12-31-6,664,771USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3140,634,157USD365
2012-01-01 to 2012-12-316,609,921USD366
2011-01-01 to 2011-12-3110,138,683USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-3,025,414USD365
2012-01-01 to 2012-12-31-636,502USD366
2011-01-01 to 2011-12-31-702,508USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-73,795,575USD
At 2012-12-31-69,683,722USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-01-01 to 2013-12-3196,285,504shares365
2012-01-01 to 2012-12-3181,646,295shares366
2011-01-01 to 2011-12-3172,450,337shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-01-01 to 2013-12-3196,285,504shares365
2012-01-01 to 2012-12-3181,646,295shares366
2011-01-01 to 2011-12-3172,450,337shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-3199,614USD365
2012-01-01 to 2012-12-310USD366
2011-01-01 to 2011-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-314,086,106USD
At 2012-12-311,071,625USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-316,009,176USD365
2012-01-01 to 2012-12-312,538,721USD366
2011-01-01 to 2011-12-311,659,083USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-2,638,567USD365
2012-01-01 to 2012-12-31-5,355,383USD366
2011-01-01 to 2011-12-31-9,761,016USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3165,388,771USD
At 2012-12-3118,088,791USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-3145,233USD365
2012-01-01 to 2012-12-31592,892USD366
2011-01-01 to 2011-12-31117,818USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-319,607,867USD
At 2012-12-315,017,201USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-12-314,040,443USD
At 2012-12-314,040,443USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-12-3110,170,573USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-3116,092,836USD
At 2012-12-317,653,561USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-12-313,880,776USD
At 2012-12-313,022,784USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-10-01 to 2013-12-3114,882,616USD92
2013-01-01 to 2013-12-3149,852,620USD365
2013-07-01 to 2013-09-3014,002,270USD92
2013-04-01 to 2013-06-3011,316,261USD91
2013-01-01 to 2013-03-319,651,473USD90
2012-10-01 to 2012-12-318,820,402USD92
2012-01-01 to 2012-12-3121,865,395USD366
2012-07-01 to 2012-09-306,528,710USD92
2012-04-01 to 2012-06-303,769,330USD91
2012-01-01 to 2012-03-312,746,953USD91
2011-10-01 to 2011-12-311,719,125USD92
2011-01-01 to 2011-12-314,402,537USD365
2011-07-01 to 2011-09-301,265,584USD92
2011-04-01 to 2011-06-301,084,458USD91
2011-01-01 to 2011-03-31333,370USD90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-01-01 to 2013-12-3146,225,657USD365
2012-01-01 to 2012-12-3119,590,446USD366
2011-01-01 to 2011-12-319,845,529USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-314,843,457USD365
2012-01-01 to 2012-12-312,884,546USD366
2011-01-01 to 2011-12-312,976,313USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-31104,375,614shares
At 2012-12-3188,373,169shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-31147,284,219USD
At 2012-12-3189,627,601USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-316,387,976USD
At 2012-12-313,351,465USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-312,301,870USD
At 2012-12-312,279,840USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-12-3111,178,573USD
At 2012-12-3111,911,749USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-310USD
At 2012-12-3170,000USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-311,517,956USD
At 2012-12-31353,333USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-311,405,974USD
At 2012-12-31990,697USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-12-311,337,408USD
At 2012-12-31657,961USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-12-310USD
At 2012-12-310USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-31637,246USD365
2012-01-01 to 2012-12-31465,367USD366
2011-01-01 to 2011-12-31446,502USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,053,971USD365
2012-01-01 to 2012-12-311,380,241USD366
2011-01-01 to 2011-12-311,335,908USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-318,439,275USD365
2012-01-01 to 2012-12-315,761,642USD366
2011-01-01 to 2011-12-311,208,456USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31857,992USD365
2012-01-01 to 2012-12-312,310,182USD366
2011-01-01 to 2011-12-31253,942USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,208,747USD365
2012-01-01 to 2012-12-31-81,112USD366
2011-01-01 to 2011-12-31732,938USD365

Inspect the source

Entity
MiMedx Group, Inc. / CIK 0001376339
Captured
2026-09-20T07:57:36.232Z
SEC response SHA-256
5e04729db5aedaa7bd3f6ae5bc7af9505652b1ffe2dd057948bb9a9c667e716d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001376339.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))